These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24806476)

  • 1. Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits.
    Puvenna V; Brennan C; Shaw G; Yang C; Marchi N; Bazarian JJ; Merchant-Borna K; Janigro D
    PLoS One; 2014; 9(5):e96296. PubMed ID: 24806476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Assessment of Acute Blood Markers of Brain Injury in Sport-Related Concussion.
    Meier TB; Nelson LD; Huber DL; Bazarian JJ; Hayes RL; McCrea MA
    J Neurotrauma; 2017 Nov; 34(22):3134-3142. PubMed ID: 28699381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of repeated blood-brain barrier disruption in football players.
    Marchi N; Bazarian JJ; Puvenna V; Janigro M; Ghosh C; Zhong J; Zhu T; Blackman E; Stewart D; Ellis J; Butler R; Janigro D
    PLoS One; 2013; 8(3):e56805. PubMed ID: 23483891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confounding factors of the expression of mTBI biomarkers, S100B, GFAP and UCH-L1 in an aging population.
    Calluy E; Beaudart C; Alokail MS; Al-Daghri NM; Bruyère O; Reginster JY; Cavalier E; Ladang A
    Clin Chem Lab Med; 2024 Sep; 62(10):2062-2069. PubMed ID: 38643415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
    Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
    World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
    Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
    J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of ubiquitin C terminal hydrolase and S100β with cognitive deficits in young adults with mild traumatic brain injury.
    Dey S; Gangadharan J; Deepika A; Kumar JK; Christopher R; Ramesh SS; Devi BI; Shukla DP
    Neurol India; 2017; 65(4):761-766. PubMed ID: 28681747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.
    Mondello S; Linnet A; Buki A; Robicsek S; Gabrielli A; Tepas J; Papa L; Brophy GM; Tortella F; Hayes RL; Wang KK
    Neurosurgery; 2012 Mar; 70(3):666-75. PubMed ID: 21937927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
    Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
    J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal Biomarker Ubiquitin C-Terminal Hydrolase Detects Traumatic Intracranial Lesions on Computed Tomography in Children and Youth with Mild Traumatic Brain Injury.
    Papa L; Mittal MK; Ramirez J; Silvestri S; Giordano P; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano D; Zonfrillo MR
    J Neurotrauma; 2017 Jul; 34(13):2132-2140. PubMed ID: 28158951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury.
    Blyth BJ; Farahvar A; He H; Nayak A; Yang C; Shaw G; Bazarian JJ
    J Neurotrauma; 2011 Dec; 28(12):2453-62. PubMed ID: 21428722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
    Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concussion BASICS II: Baseline serum biomarkers, head impact exposure, and clinical measures.
    Asken BM; Bauer RM; DeKosky ST; Houck ZM; Moreno CC; Jaffee MS; Dubose DN; Boone JK; Weber AG; Clugston JR
    Neurology; 2018 Dec; 91(23):e2123-e2132. PubMed ID: 30404782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
    Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
    Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of GFAP and UCH-L1 Measurements Using Two Automated Immunoassays (i-STAT
    Oris C; Khatib-Chahidi C; Pereira B; Bailly Defrance V; Bouvier D; Sapin V
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI.
    Berger RP; Hayes RL; Richichi R; Beers SR; Wang KK
    J Neurotrauma; 2012 Jan; 29(1):162-7. PubMed ID: 22022780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
    Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
    J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minor head injury in anticoagulated patients: performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study.
    Menditto VG; Moretti M; Babini L; Mattioli A; Giuliani AR; Fratini M; Pallua FY; Andreoli E; Nitti C; Contucci S; Gabrielli A; Rocchi MBL; Pomponio G
    Clin Chem Lab Med; 2024 Jun; 62(7):1376-1382. PubMed ID: 38206121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.